Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.869 USD | +12.26% | +27.79% | +174.57% |
22/04 | Benitec Biopharma Inc. announced that it has received $40.000019 million in funding from a group of investors | CI |
18/04 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 115M 75.82M 6.32B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.58
x | P/E ratio 2025 * |
-4.98
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.58% |
1 day | +12.26% | ||
1 week | +27.79% | ||
Current month | +4.95% | ||
1 month | +67.33% | ||
3 months | +215.10% | ||
6 months | +145.67% | ||
Current year | +174.57% |
Managers | Title | Age | Since |
---|---|---|---|
Jerel Banks
CEO | Chief Executive Officer | 49 | 01/16/01 |
Peter Roelvink
CTO | Chief Tech/Sci/R&D Officer | - | 01/15/01 |
Megan Boston
CMP | Compliance Officer | 52 | 01/16/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Buchi
BRD | Director/Board Member | 69 | 01/13/01 |
Edward Smith
BRD | Director/Board Member | 53 | 14/20/14 |
Peter Francis
BRD | Director/Board Member | 68 | 01/06/01 |
Date | Price | Change | Volume |
---|---|---|---|
02/24/02 | 8.869 | +12.26% | 61,235 |
01/24/01 | 7.9 | -6.51% | 38,143 |
30/24/30 | 8.45 | +13.73% | 84,957 |
29/24/29 | 7.43 | +7.68% | 26,954 |
26/24/26 | 6.9 | -0.58% | 19,769 |
Delayed Quote Nasdaq, May 03, 2024 at 02:00 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+174.57% | 75.37M | |
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+47.02% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |
- Stock Market
- Equities
- BNTC Stock